Endologix
Endologix, Inc. specializes in developing, manufacturing, and marketing medical devices aimed at treating abdominal aortic aneurysms (AAA) both in the United States and internationally. The company's product portfolio includes minimally invasive endovascular aneurysm repair (EVAR) systems, such as the AFX endovascular AAA system, the VELA Proximal Endograft, and the Ovation abdominal stent graft system. Endologix also offers the endovascular aneurysm sealing system (EVAS), which utilizes the Nellix technology to seal aneurysms while maintaining blood flow to the legs. In addition to these core products, the company provides various extensions and delivery accessories to enhance the customization and application of its devices. Endologix primarily sells its products through a direct sales force, complemented by a network of third-party distributors and agents. Founded in 1992 and headquartered in Irvine, California, the company was previously known as Radiance Medical Systems, Inc. before rebranding in 2002.
PQ Bypass, Inc. is a medical device company based in Milpitas, California, focused on developing innovative solutions for peripheral vascular disease through minimally-invasive techniques. Founded in 2009, PQ Bypass specializes in products designed for the treatment of long-segment femoropopliteal disease, including the DETOUR System, PQ Snare, PQ Crossing Device, and TORUS Stent Graft System. The company aims to transform the treatment landscape for peripheral artery disease by providing effective endovascular options. Its leadership team comprises experienced professionals with backgrounds in major medical device firms and successful startups, bringing a wealth of expertise to the development of its advanced medical technologies.
TriVascular Technologies, Inc. is a medical device company focused on developing and commercializing technologies for the minimally invasive treatment of abdominal aortic aneurysms (AAA) and thoracic aortic conditions. The company is known for its Ovation System, which includes a stent graft platform designed for endovascular aortic repair. Key components of the Ovation System feature an aortic body, iliac limbs, and polymer fill, which contribute to its effectiveness in treating AAA. TriVascular markets its products through direct sales in the United States and several European countries, as well as via distributors in other regions. Founded in 2007 and headquartered in Santa Rosa, California, TriVascular has been recognized for its innovative approach to addressing unmet clinical needs in aortic disease treatment. The company operates as a subsidiary of Endologix Inc.
Nellix is a medical device company focused on developing innovative solutions for the treatment of Abdominal Aortic Aneurysms (AAAs) and Thoracic Aortic Aneurysms (TAAs). The company's flagship device features a low-profile delivery system and a unique endograft, which allows for less invasive procedures and expands the range of treatable aneurysms. This technology has the potential to significantly increase the market size for Endovascular Aneurysm Repair (EVAR), which has been growing steadily. Nellix aims to improve patient outcomes by providing effective surgical devices that support blood flow through damaged arteries, thereby addressing a critical need in vascular surgery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.